BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wan S, Hann HW, Myers RE, Fu X, Hann RS, Kim SH, Tang H, Xing J, Yang H. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis. Liver Int 2012;32:1233-41. [PMID: 22471856 DOI: 10.1111/j.1478-3231.2012.02801.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Wan S, Hann HW, Ye Z, Hann RS, Lai Y, Wang C, Li L, Myers RE, Li B, Xing J, Yang H. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients. Carcinogenesis 2017;38:439-46. [PMID: 28334112 DOI: 10.1093/carcin/bgx021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Caini S, Raimondi S, Johansson H, De Giorgi V, Zanna I, Palli D, Gandini S. Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis. J Dermatol Sci 2015;80:168-74. [PMID: 26341697 DOI: 10.1016/j.jdermsci.2015.08.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
3 Ma Q, Cai J, Cai Y, Xu Y, Chang F, Xu L, Zhang G, Guo X. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e4970. [PMID: 27684844 DOI: 10.1097/MD.0000000000004970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang W, Chen H, Li R, Ouyang N, Chen J, Huang L, Mai M, Zhang N, Zhang Q, Yang D. Telomerase activity is more significant for predicting the outcome of IVF treatment than telomere length in granulosa cells. Reproduction 2014;147:649-57. [PMID: 24472817 DOI: 10.1530/REP-13-0223] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
5 Lonardo A, Lugari S, Nascimbeni F. Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk? Liver Int 2018;38:1730-2. [PMID: 30256511 DOI: 10.1111/liv.13935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Zinkova A, Brynychova I, Svacina A, Jirkovska M, Korabecna M. Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response. Sci Rep 2017;7:2591. [PMID: 28572683 DOI: 10.1038/s41598-017-02905-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
7 Czaja AJ. Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci. 2013;58:1459-1476. [PMID: 23306849 DOI: 10.1007/s10620-012-2525-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
8 Hann HW, Wan S, Lai Y, Hann RS, Myers RE, Patel F, Zhang K, Ye Z, Wang C, Yang H. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2015;30:131-8. [PMID: 24995497 DOI: 10.1111/jgh.12664] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
9 Benati M, Montagnana M, Danese E, Mazzon M, Paviati E, Garzon S, Laganà AS, Casarin J, Giudici S, Raffaelli R, Ghezzi F, Franchi M, Lippi G. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer. Pathol Oncol Res 2020;26:2281-9. [PMID: 32462419 DOI: 10.1007/s12253-020-00819-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
10 Zhou G, Li Y, Li S, Liu H, Xu F, Lai X, Zhang Q, Xu J, Wan S. Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine. Front Genet 2021;12:719451. [PMID: 34603382 DOI: 10.3389/fgene.2021.719451] [Reference Citation Analysis]
11 Wu H, Zou W, Zhou D, Gu Y, Liao Z, Li Z. Longer Leukocyte Telomere Length is Associated With an Increased Risk of Chronic Pancreatitis. Pancreas 2017;46:e65-6. [DOI: 10.1097/mpa.0000000000000887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 Axelrad MD, Budagov T, Atzmon G. Telomere length and telomerase activity; a Yin and Yang of cell senescence. J Vis Exp 2013;:e50246. [PMID: 23728273 DOI: 10.3791/50246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Srinivasa S, Fitch KV, Petrow E, Burdo TH, Williams KC, Lo J, Cȏté HCF, Grinspoon SK. Soluble CD163 is associated with shortened telomere length in HIV-infected patients. J Acquir Immune Defic Syndr 2014;67:414-8. [PMID: 25197827 DOI: 10.1097/QAI.0000000000000329] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Wang C, Hann HW, Hann RS, Wan S, Myers RE, Ye Z, Xing J, Yang H. Circulating mitochondrial DNA content associated with the risk of liver cirrhosis: a nested case-control study. Dig Dis Sci 2015;60:1707-15. [PMID: 25588520 DOI: 10.1007/s10620-015-3523-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]